Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravit Geva

Showing results (11-20 of 90) with videos related to

Pageof 9
Sort By:
Pancreas|September 20, 2011
Effect of tumor load on energy expenditure in patients with pancreatic cancerNachum Vaisman, Michal Lusthaus, Eva Niv, et al.
World Journal of Surgery|February 24, 2009
Is there a survival benefit to neoadjuvant versus adjuvant chemotherapy, combined with surgery for resectable colorectal liver metastases?Nir Lubezky, Ravit Geva, Einat Shmueli, et al.
The Israel Medical Association Journal : IMAJ|June 16, 2026
Low Disease Burden in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Is Associated with Improved Outcomes: A Single Center ExperienceYossi Maman, Jawad Tome, Rina Neeman, et al.
Journal of Cancer Research and Clinical Oncology|May 23, 2014
Is there a role for adjuvant chemotherapy in pathological complete response rectal cancer tumors following neoadjuvant chemoradiotherapy?Ravit Geva, Eran Itzkovich, Sivan Shamai, et al.
Journal of Clinical Pharmacology|January 11, 2012
Phase I trial of sorafenib in combination with 5-fluorouracil/leucovorin in advanced solid tumorsEinat Shacham-Shmueli, Ravit Geva, Arie Figer, et al.
Cancer|August 19, 2020
First-in-human phase 1 study of MK-1248, an anti-glucocorticoid-induced tumor necrosis factor receptor agonist monoclonal antibody, as monotherapy or with pembrolizumab in patients with advanced solid tumorsRavit Geva, Mark Voskoboynik, Konstantin Dobrenkov, et al.
Investigational New Drugs|January 20, 2020
Pharmacokinetics of mitomycin-c lipidic prodrug entrapped in liposomes and clinical correlations in metastatic colorectal cancer patientsAlberto A Gabizon, Esther Tahover, Talia Golan, et al.
Future Oncology (London, England)|June 26, 2019
Ramucirumab and paclitaxel in patients with gastric cancer and prior trastuzumab: subgroup analysis from RAINBOW studyFerdinando De Vita, Christophe Borg, Gabriella Farina, et al.
Annals of Surgical Oncology|February 2, 2006
Can rectal cancers with pathologic T0 after neoadjuvant chemoradiation (ypT0) be treated by transanal excision alone?Hagit Tulchinsky, Micha Rabau, Einat Shacham-Shemueli, et al.
The American Journal of Gastroenterology|June 3, 2005
Genetic analyses in consecutive israeli jewish colorectal cancer patientsHerma H Fidder, Arie Figer, Ravit Geva, et al.
Pageof 9

Showing results (11-20 of 90) with videos related to

Sort By:
Pageof 9
Pancreas|September 20, 2011
Effect of tumor load on energy expenditure in patients with pancreatic cancerNachum Vaisman, Michal Lusthaus, Eva Niv, et al.
World Journal of Surgery|February 24, 2009
Is there a survival benefit to neoadjuvant versus adjuvant chemotherapy, combined with surgery for resectable colorectal liver metastases?Nir Lubezky, Ravit Geva, Einat Shmueli, et al.
The Israel Medical Association Journal : IMAJ|June 16, 2026
Low Disease Burden in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Is Associated with Improved Outcomes: A Single Center ExperienceYossi Maman, Jawad Tome, Rina Neeman, et al.
Journal of Cancer Research and Clinical Oncology|May 23, 2014
Is there a role for adjuvant chemotherapy in pathological complete response rectal cancer tumors following neoadjuvant chemoradiotherapy?Ravit Geva, Eran Itzkovich, Sivan Shamai, et al.
Journal of Clinical Pharmacology|January 11, 2012
Phase I trial of sorafenib in combination with 5-fluorouracil/leucovorin in advanced solid tumorsEinat Shacham-Shmueli, Ravit Geva, Arie Figer, et al.
Cancer|August 19, 2020
First-in-human phase 1 study of MK-1248, an anti-glucocorticoid-induced tumor necrosis factor receptor agonist monoclonal antibody, as monotherapy or with pembrolizumab in patients with advanced solid tumorsRavit Geva, Mark Voskoboynik, Konstantin Dobrenkov, et al.
Investigational New Drugs|January 20, 2020
Pharmacokinetics of mitomycin-c lipidic prodrug entrapped in liposomes and clinical correlations in metastatic colorectal cancer patientsAlberto A Gabizon, Esther Tahover, Talia Golan, et al.
Future Oncology (London, England)|June 26, 2019
Ramucirumab and paclitaxel in patients with gastric cancer and prior trastuzumab: subgroup analysis from RAINBOW studyFerdinando De Vita, Christophe Borg, Gabriella Farina, et al.
Annals of Surgical Oncology|February 2, 2006
Can rectal cancers with pathologic T0 after neoadjuvant chemoradiation (ypT0) be treated by transanal excision alone?Hagit Tulchinsky, Micha Rabau, Einat Shacham-Shemueli, et al.
The American Journal of Gastroenterology|June 3, 2005
Genetic analyses in consecutive israeli jewish colorectal cancer patientsHerma H Fidder, Arie Figer, Ravit Geva, et al.
Pageof 9